Acellular collagen-glycosaminoglycan matrix promotes functional recovery in a rat model of volumetric muscle loss

被引:2
作者
Zhu, Christina [1 ,2 ]
Karvar, Mehran [1 ]
Koh, Daniel J. [1 ,3 ]
Sklyar, Karina [1 ]
Endo, Yori [1 ]
Quint, Jacob [4 ]
Samandari, Mohamadmahdi [4 ]
Tamayol, Ali [4 ]
Sinha, Indranil [1 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Div Plast Surg, Boston, MA 02115 USA
[2] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Lubbock, TX 79430 USA
[3] Boston Univ, Chobanian & Avedisian Sch Med, Boston, MA 02118 USA
[4] Univ Connecticut, Dept Biomed Engn, Farmington, CT 06269 USA
关键词
collagen-glycosaminoglycan; regenerative medicine; scaffold; tissue engineering; volumetric muscle loss; SKELETAL-MUSCLE; BIOLOGIC SCAFFOLD; LOSS INJURY; TISSUE; TRANSPLANTATION; RECONSTRUCTION; REGENERATION; INTEGRA; SKIN;
D O I
10.2217/rme-2023-0060
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Plain language summaryVolumetric muscle loss (VML) is a large injury to skeletal muscle. VML heals with scarring, little muscle regeneration, and incomplete strength recovery. The current treatment for VML involves transferring muscle from one part of the body to the injury site. However, this is limited by weakness of the donor site and incomplete recovery of muscle function. Therefore, other treatments have been developed to aid in muscle healing. One such treatment involves using three dimensional templates, known as scaffolds, to aid in muscle regeneration. Our goal is to determine whether a collagen-glycosaminoglycan scaffold (CGS), which is already used for other medical purposes, can improve healing of VML injuries in rats. CGS placement in rat muscle injuries resulted in decreased scarring, increased muscle regeneration, and increased strength recovery compared with the non-CGS group. Tweetable abstractAcellular collagen-glycosaminoglycan scaffolds promote functional recovery, reduced fibrosis and increased muscle regeneration in a rat model of volumetric muscle loss. Aim: Volumetric muscle loss (VML) is a composite loss of skeletal muscle, which heals with fibrosis, minimal muscle regeneration, and incomplete functional recovery. This study investigated whether collagen-glycosaminoglycan scaffolds (CGS) improve functional recovery following VML. Methods: 15 Sprague-Dawley rats underwent either sham injury or bilateral tibialis anterior (TA) VML injury, with or without CGS implantation. Results: In rats with VML injuries treated with CGS, the TA exhibited greater in vivo tetanic forces and in situ twitch and tetanic dorsiflexion forces compared with those in the non-CGS group at 4- and 6-weeks following injury, respectively. Histologically, the VML with CGS group demonstrated reduced fibrosis and increased muscle regeneration. Conclusion: Taken together, CGS implantation has potential augment muscle recovery following VML.
引用
收藏
页码:623 / 633
页数:12
相关论文
共 45 条
  • [1] Multiscale analysis of a regenerative therapy for treatment of volumetric muscle loss injury
    Aguilar, Carlos A.
    Greising, Sarah M.
    Watts, Alain
    Goldman, Stephen M.
    Peragallo, Chelsea
    Zook, Christina
    Larouche, Jacqueline
    Corona, Benjamin T.
    [J]. CELL DEATH DISCOVERY, 2018, 4
  • [2] Asif Mohammed, 2018, JPRAS Open, V17, P15, DOI 10.1016/j.jpra.2018.04.003
  • [3] An acellular biologic scaffold does not regenerate appreciable de novo muscle tissue in rat models of volumetric muscle loss injury
    Aurora, Amit
    Roe, Janet L.
    Corona, Benjamin T.
    Walters, Thomas J.
    [J]. BIOMATERIALS, 2015, 67 : 393 - 407
  • [4] Skeletal muscle tissue engineering
    Bach, AD
    Beier, JP
    Stern-Staeter, J
    Horch, RE
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2004, 8 (04): : 413 - 422
  • [5] Role of proteoglycans in the regulation of the skeletal muscle fibrotic response
    Brandan, Enrique
    Gutierrez, Jaime
    [J]. FEBS JOURNAL, 2013, 280 (17) : 4109 - 4117
  • [6] SUCCESSFUL USE OF A PHYSIOLOGICALLY ACCEPTABLE ARTIFICIAL SKIN IN THE TREATMENT OF EXTENSIVE BURN INJURY
    BURKE, JF
    YANNAS, IV
    QUINBY, WC
    BONDOC, CC
    JUNG, WK
    [J]. ANNALS OF SURGERY, 1981, 194 (04) : 413 - 428
  • [7] Autologous minced muscle grafts: a tissue engineering therapy for the volumetric loss of skeletal muscle
    Corona, B. T.
    Garg, K.
    Ward, C. L.
    McDaniel, J. S.
    Walters, T. J.
    Rathbone, C. R.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2013, 305 (07): : C761 - C775
  • [8] Inflammatory and Physiological Consequences of Debridement of Fibrous Tissue after Volumetric Muscle Loss Injury
    Corona, Benjamin T.
    Rivera, Jessica C.
    Greising, Sarah M.
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2018, 11 (02): : 208 - 217
  • [9] Pathophysiology of Volumetric Muscle Loss Injury
    Corona, Benjamin T.
    Wenke, Joseph C.
    Ward, Catherine L.
    [J]. CELLS TISSUES ORGANS, 2015, 202 (3-4) : 180 - 188
  • [10] Challenges to acellular biological scaffold mediated skeletal muscle tissue regeneration
    Corona, Benjamin T.
    Greising, Sarah M.
    [J]. BIOMATERIALS, 2016, 104 : 238 - 246